Jason Arsenault

Jason Arsenault

Auto-generated profile, based on publicly available information

Jason Arsenault

Hospital for Sick Children

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BTBrian Tsang
Brian Tsang
JAJason Arsenault
Jason Arsenault
RVRobert M. Vernon
Robert M. Vernon
HLHong Lin
Hong Lin
NSNahum Sonenberg
Nahum Sonenberg
JFJulie Forman-Kay
Julie Forman-Kay
Activity-dependent translation requires the transport of mRNAs within membraneless protein assemblies known as neuronal granules from the cell body toward synaptic regions. Translation of mRNA is inhibited in these granules during transport but quickly activated in response to neuronal stimuli at the synapse. This raises an important question: how does synaptic activity trigger translation of once-silenced mRNAs? Here, we demonstrate a strong connection between phase separation, the process underlying the formation of many different types of cellular granules, and in vitro inhibition of translation. By using the Fragile X Mental Retardation Protein (FMRP), an abundant neuronal granule component and translational repressor, we show that FMRP phase separates in vitro with RNA into liquid droplets mediated by its C-terminal low-complexity disordered region (i.e., FMRPLCR). FMRPLCR posttranslational modifications by phosphorylation and methylation have opposing effects on in vitro translational regulation, which corroborates well with their critical concentrations for phase separation. Our results, combined with bioinformatics evidence, are supportive of phase separation as a general mechanism controlling activity-dependent translation. Significance Activity-dependent translation, the reversible activation of translation in response to synaptic activity, is important for synaptic plasticity and long-term memory formation. How synaptic activity triggers translation of silenced mRNAs within neuronal granules, which are membraneless RNA–protein assemblies, is not clear. We show that the C-terminal region of the Fragile X Mental Retardation Protein (FMRP), an abundant neuronal granule protein, phase separates in vitro with RNA and that its phase separation is fine-tuned by posttranslational modifications controlled in neurons by synaptic activity. We observe that phase separation is correlated with translation inhibition in vitro, providing a conceptual framework to unify FMRP’s diverse roles. Experimental and bioinformatic data suggest that phase separation may be a general mechanism linked to activity-dependent translation.

7 July 2014 in Neuropsychopharmacology
Verified
Journal Article
Closed access
SGShervin Gholizadeh
Shervin Gholizadeh
JAJason Arsenault
Jason Arsenault
IXIngrid Cong Yang Xuan
Ingrid Cong Yang Xuan
LPLaura K Pacey
Laura K Pacey
DHDavid R. Hampson
David R. Hampson

9 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAndrew P. Burke
Andrew P. Burke
YNYosuke Niibori
Yosuke Niibori
HTHayato Terayama
Hayato Terayama
MIMasatoshi Ito
Masatoshi Ito
CPCharlotte Pidgeon
Charlotte Pidgeon
DHDavid R. Hampson
David R. Hampson
Neonicotinoids have become the most widely used class of insecticides world-wide. Although numerous studies have documented neonicotinoid toxicity in bees and other insects, the effects of exposure during early development in mammals remain largely unexplored. We assessed the effects of the neonicotinoid imidacloprid (IMI) in adult male and female mice after in utero and early postnatal exposure. Pregnant mice were infused with IMI (0.5 mg/kg/day) from gestational day 4 to the end of nursing at postnatal day 21. The young adult offspring were studied in a series of biochemical and behavioral tests. To assess reproducibility, the behavioral analyses were conducted in three separate studies using multiple exposed litters. Exposure to IMI reduced fecundity, and in adult offspring, decreased body weight in male but not female pups. Offspring from IMI-treated mothers displayed lower triglycerides, elevated motor activity, enhanced social dominance, reduced depressive-like behavior, and a diminution in social aggression compared to vehicle treated controls. Low levels of IMI were detected in the brains and livers of the treated mothers, while trace levels were detected in some offspring. Our results demonstrate that transient exposure to a neonicotinoid over the early developmental period induces long-lasting changes in behavior and brain function in mice.

1 December 2016 in Human Gene Therapy
Verified
Journal Article
Open access
JAJason Arsenault
Jason Arsenault
SGShervin Gholizadeh
Shervin Gholizadeh
YNYosuke Niibori
Yosuke Niibori
LPLaura K. Pacey
Laura K. Pacey
Sebok Kumar HalderSebok Kumar Halder
Sebok Kumar Halder
DHDavid R. Hampson
David R. Hampson
Fragile X mental retardation protein (FMRP) is absent or highly reduced in Fragile X Syndrome, a genetic disorder causing cognitive impairment and autistic behaviors. Previous proof-of-principle studies have demonstrated that restoring FMRP in the brain using viral vectors can improve pathological abnormalities in mouse models of fragile X. However, unlike small molecule drugs where the dose can readily be adjusted during treatment, viral vector–based biological therapeutic drugs present challenges in terms of achieving optimal dosing and expression levels. The objective of this study was to investigate the consequences of expressing varying levels of FMRP selectively in neurons of Fmr1 knockout and wild-type (WT) mice. A wide range of neuronal FMRP transgene levels was achieved in individual mice after intra-cerebroventricular administration of adeno-associated viral vectors coding for FMRP. In all treated knockout mice, prominent FMRP transgene expression was observed in forebrain structures, whereas lower levels were present in more caudal regions of the brain. Reduced levels of the synaptic protein PSD-95, elevated levels of the transcriptional modulator MeCP2, and abnormal motor activity, anxiety, and acoustic startle responses in Fmr1 knockout mice were fully or partially rescued after expression of FMRP at about 35–115% of WT expression, depending on the brain region examined. In the WT mouse, moderate FMRP over-expression of up to about twofold had little or no effect on PSD-95 and MeCP2 levels or on behavioral endophenotypes. In contrast, excessive over-expression in the Fmr1 knockout mouse forebrain (approximately 2.5–6-fold over WT) induced pathological motor hyperactivity and suppressed the startle response relative to WT mice. These results delineate a range of FMRP expression levels in the central nervous system that confer phenotypic improvement in fragile X mice. Collectively, these findings are pertinent to the development of long-term curative gene therapy strategies for treating Fragile X Syndrome and other neurodevelopmental disorders.

17 September 2018 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
YYYi-Mei Yang
Yi-Mei Yang
JAJason Arsenault
Jason Arsenault
ABAlaji Bah
Alaji Bah
MKMickael Krzeminski
Mickael Krzeminski
AFAdam Fekete
Adam Fekete
LWLu-Yang Wang
Lu-Yang Wang
Principal neurons encode information by varying their firing rate and patterns precisely fine-tuned through GABAergic interneurons. Dysregulation of inhibition can lead to neuropsychiatric disorders, yet little is known about the molecular basis underlying inhibitory control. Here, we find that excessive GABA release from basket cells (BCs) attenuates the firing frequency of Purkinje neurons (PNs) in the cerebellum of Fragile X Mental Retardation 1 (Fmr1) knockout (KO) mice, a model of Fragile X Syndrome (FXS) with abrogated expression of the Fragile X Mental Retardation Protein (FMRP). This over-inhibition originates from increased excitability and Ca2+transients in the presynaptic terminals, where Kv1.2 potassium channels are downregulated. By paired patch-clamp recordings, we further demonstrate that acutely introducing an N-terminal fragment of FMRP into BCs normalizes GABA release in theFmr1-KO synapses. Conversely, direct injection of an inhibitory FMRP antibody into BCs, or membrane depolarization of BCs, enhances GABA release in the wild type synapses, leading to abnormal inhibitory transmission comparable to theFmr1-KO neurons. We discover that the N-terminus of FMRP directly binds to a phosphorylated serine motif on the C-terminus of Kv1.2; and that loss of this interaction in BCs exaggerates GABA release, compromising the firing activity of PNs and thus the output from the cerebellar circuitry. An allosteric Kv1.2 agonist, docosahexaenoic acid, rectifies the dysregulated inhibition in vitro as well as acoustic startle reflex and social interaction in vivo of theFmr1-KO mice. Our results unravel a novel molecular locus for targeted intervention of FXS and perhaps autism.

20 September 2013 in Bioconjugate Chemistry
Verified
Journal Article
Open access
Enrico FerrariEnrico Ferrari
Enrico Ferrari
CGChunjing Gu
Chunjing Gu
DNDhevahi Niranjan
Dhevahi Niranjan
Laura RestaniLaura Restani
Laura Restani
CRChristine Rasetti-Escargueil
Christine Rasetti-Escargueil
BDBazbek Davletov
Bazbek Davletov
Clostridial neurotoxins reversibly block neuronal communication for weeks and months. While these proteolytic neurotoxins hold great promise for clinical applications and the investigation of brain function, their paralytic activity at neuromuscular junctions is a stumbling block. To redirect the clostridial activity to neuronal populations other than motor neurons, we used a new self-assembling method to combine the botulinum type A protease with the tetanus binding domain, which natively targets central neurons. The two parts were produced separately and then assembled in a site-specific way using a newly introduced ‘protein stapling’ technology. Atomic force microscopy imaging revealed dumbbell shaped particles which measure ∼23 nm. The stapled chimera inhibited mechanical hypersensitivity in a rat model of inflammatory pain without causing either flaccid or spastic paralysis. Moreover, the synthetic clostridial molecule was able to block neuronal activity in a defined area of visual cortex. Overall, we provide the first evidence that the protein stapling technology allows assembly of distinct proteins yielding new biomedical properties.